Premium
Synthesis and Cannabinoid Receptor Activity of Ketoalkenes from Echinacea pallida and Nonnatural Analogues
Author(s) -
Egger Michael,
Pellett Patrina,
Nickl Kathrin,
Geiger Sarah,
Graetz Stephanie,
Seifert Roland,
Heilmann Jörg,
König Burkhard
Publication year - 2008
Publication title -
chemistry – a european journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.687
H-Index - 242
eISSN - 1521-3765
pISSN - 0947-6539
DOI - 10.1002/chem.200801579
Subject(s) - echinacea (animal) , cannabinoid , receptor , cannabinoid receptor , stereochemistry , potency , chemistry , pharmacology , biology , traditional medicine , biochemistry , in vitro , medicine , agonist
Despite its popularity and widespread use, the efficacy of Echinacea products remains unclear and controversial. Among the various compounds isolated from Echinacea , ketoalkenes and ketoalkenynes exclusively found in the pale purple coneflower ( E. pallida ) are major components of the extracts. In contrast to E. purpurea alkamides, these compounds have not been synthesized and studied for immunostimulatory effects. We present a practical and useful synthetic approach to the ketoalkenes using palladium‐catalyzed cross‐coupling reactions and the pharmaceutical results at the human cannabinoid receptors. The synthetic route developed provides overall good yields for the ketoalkenes and is applicable to other natural products with similar 1,4‐diene motifs. No significant activity was observed at either receptor, indicating that the ketoalkenes from E. pallida are not responsible for immunomodulatory effects mediated via the cannabinergic system. However, newly synthesized non‐natural analogues showed micro‐molar potency at both cannabinoid receptors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom